Simplification for success: Rewiring the biopharma operating model
To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work, speed up decision-making, and harness AI and digital.
To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work, speed up decision-making, and harness AI and digital.
